GSK3B and Parkinson disease: Additionally, compared with the control group, the PD group showed markedly higher expression of proapoptosis proteins (Bax, caspase-3, GSK-3β, and β-catenin) and a much lower expression level of an antiapoptosis protein (Bcl2) (Figure 6(b)).